In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
The in vitro antibacterial activity of pefloxacin was evaluated against 310 gram-negative and 315 gram-positive aerobes, freshly isolated from clinical material. Reference antibiotics were: ofloxacin, ciprofloxacin, teicoplanin, vancomycin, rifampin, and methicillin for gram-positive cocci, and norfloxacin, nalidixic acid, ceftazidime, cefotaxime, piperacillin, netilmicin, gentamicin, amikacin, and aztreonam, for gram-negative bacilli. Gram-positive cocci were inhibited by 0.5 mg/l of teicoplanin, 1 mg/l of ciprofloxacin, 4 mg/l of both pefloxacin and ofloxacin, and 8 mg/l of vancomycin or rifampicin. Against gram-negative bacteria pefloxacin showed excellent activity, inhibiting 90% of all enterobacterial strains and 70% of other gram-negative aerobes at concentrations ranging between 0.03 and 4 mg/l. The same percentage of bacteria were inhibited by the other drugs at concentrations which resulted from two to fourfold higher than those of pefloxacin. MBCs and timed-kill tests indicated that this new agent is rapidly bactericidal against these isolates, and there were no significant differences in the rate of killing of both gram-positive and gram-negative bacteria. Inoculum size and pH did not change significantly the MIC values of pefloxacin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D004755:Enterobacteriaceae / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009643:Norfloxacin / Q000031:analogs & derivatives* / Q000494:pharmacology; D015366:Pefloxacin; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D000900:Anti-Bacterial Agents; D015366:Pefloxacin; D009643:Norfloxacin